Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Joan Ritho"'
Autor:
Shaymaa Bahnassy, Hariprasad Thangavel, Maram Quttina, Ashfia Fatima Khan, Dhanya Dhanyalayam, Joan Ritho, Samaneh Karami, Jing Ren, Tasneem Bawa-Khalfe
Publikováno v:
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-11 (2020)
Abstract Background Hormone receptor positive (HR+) breast cancer (BCa) is the most frequently diagnosed subtype. Acquired and intrinsic resistance to conventional endocrine therapy (ET) commonly occurs and prompts incurable metastatic disease. Hence
Externí odkaz:
https://doaj.org/article/d4aaf94611524f299995bd2d53354d77
Publikováno v:
Cell Reports, Vol 12, Iss 5, Pp 734-742 (2015)
SUMOylation has been implicated in cellular stress adaptation, but its role in regulating liver kinase B1 (LKB1), a major upstream kinase of the energy sensor AMP-activated protein kinase (AMPK), is unknown. Here, we show that energy stress triggers
Externí odkaz:
https://doaj.org/article/45686df3df444134a1454ad036c48c2d
Autor:
Shaymaa Bahnassy, Tasneem Bawa-Khalfe, Dhanya Dhanyalayam, Samaneh Karami, Jing Ren, Ashfia Fatima Khan, Joan Ritho, Maram Quttina, Hariprasad Thangavel
Publikováno v:
Cancer Research. 81:PS17-33
Background: Conventional endocrine therapy is the first-line treatment for hormone receptor positive (HR+) breast cancer (BCa) subtype. Frequently, intrinsic and acquired ET resistance (ET-R) persists to support a disease with poor prognosis and limi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18d9746f65417a71e7aa091c5888417d
https://doi.org/10.1158/1538-7445.sabcs20-ps17-33
https://doi.org/10.1158/1538-7445.sabcs20-ps17-33
Autor:
Joan Ritho, Scott Dixon
Publikováno v:
The FASEB Journal. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a98e61bba7ca698e9341c60c7e4e9eda
https://doi.org/10.1096/fasebj.2022.36.s1.r3894
https://doi.org/10.1096/fasebj.2022.36.s1.r3894
Autor:
Joan Ritho, Scott J. Dixon
Publikováno v:
Cell chemical biology. 29(1)
Ferroptosis is an iron-dependent form of cell death implicated in cancer and neurodegenerative diseases. In this issue of Cell Chemical Biology, Shao et al. (2022) and Wang et al. (2022) describe imaging techniques to monitor ferrous iron levels and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f7d8b50b0c6baf48f835a567713901
https://pubmed.ncbi.nlm.nih.gov/34936859
https://pubmed.ncbi.nlm.nih.gov/34936859
Autor:
Hariprasad Thangavel, Samaneh Karami, Dhanya Dhanyalayam, Tasneem Bawa-Khalfe, Jing Ren, Maram Quttina, Ashfia Fatima Khan, Shaymaa Bahnassy, Joan Ritho
Publikováno v:
Cell Communication and Signaling : CCS
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-11 (2020)
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-11 (2020)
Background Hormone receptor positive (HR+) breast cancer (BCa) is the most frequently diagnosed subtype. Acquired and intrinsic resistance to conventional endocrine therapy (ET) commonly occurs and prompts incurable metastatic disease. Hence, ET-resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b723a8fffef16ab0bd0ecb1fcf72ebe7
https://doi.org/10.1186/s12964-020-00649-z
https://doi.org/10.1186/s12964-020-00649-z
Publikováno v:
Oncotarget
// Tasneem Bawa-Khalfe 1 , Feng-Ming Yang 2 , Joan Ritho 2 , Hui-Kuan Lin 3,4 , Jinke Cheng 5,6 and Edward T.H. Yeh 2 1 Department of Biology & Biochemistry, Center for Nuclear Receptors & Cell Signaling, University of Houston, Houston, Texas, USA 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6883767415b982d5219bbcaac03f1cae
https://doi.org/10.18632/oncotarget.13283
https://doi.org/10.18632/oncotarget.13283